PF-Atlas › Clinical Trials › NCT05330312
Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF
Digital cognitive behavioral therapy · Not specified
Registry ID
NCT05330312
Phase
Not specified
Status
Completed
Drug / intervention
Digital cognitive behavioral therapy
Sponsor
Vicore Pharma AB
Start
2022-04-17
Enrollment
119
Locations
2
About this trial
The purpose of the study is to assess efficacy and safety of a digital cognitive behavioural therapy for patients with pulmonary fibrosis on anxiety.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05330312 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.